Metastasis-directed therapy for oligometastatic urological tumours: still no second-hand news

For patients presenting with limited metastatic disease burden, known as the oligometastatic state of disease, a more aggressive treatment approach targeting the new or progressive metastatic lesions might improve patient outcome, with no or only limited toxicity to be expected from the treatment. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghen, Charlien, Joniau, Steven, Vulsteke, Christof, Albersen, Maarten, Devos, Gaëtan, Rans, Kato, Haustermans, Karin, De Meerleer, Gert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289610/
https://www.ncbi.nlm.nih.gov/pubmed/32565889
http://dx.doi.org/10.3332/ecancer.2020.1036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7289610/
https://www.ncbi.nlm.nih.gov/pubmed/32565889
http://dx.doi.org/10.3332/ecancer.2020.1036

Ejemplares similares